• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症发病率的种族差异:遗传性易感性的一个指标?

Ethnic differences in cancer incidence: a marker for inherited susceptibility?

作者信息

Gilliland F D

机构信息

Department of Internal Medicine and Epidemiology, University of New Mexico School of Medicine, Albuquerque 87131, USA.

出版信息

Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):897-900. doi: 10.1289/ehp.97105s4897.

DOI:10.1289/ehp.97105s4897
PMID:9255577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1470049/
Abstract

Cancer incidence varies markedly by ethnicity and geographic location. Ethnic variation in cancer occurrence has traditionally been ascribed to differences in social, cultural, economic, and physical environments. However, this interpretation of the epidemiologic evidence may need to be revised as a result of new biological evidence and theories of carcinogenesis. Carcinogenesis is now recognized to be a multistep process during which mutations or heritable changes in expression occur in genes involved in cellular growth control and genome stability. Inherited cancer susceptibility may be a stronger determinant of ethnic differences in cancer incidence than is currently appreciated. To examine the potential role of inherited susceptibility, the theoretical contribution of inherited susceptibility to ethnic differences in rates in considered using a simple probability model. Germline mutations in tumor suppressor genes BRCA1 and p53 are used to illustrate the magnitude of the ethnic differences for breast cancer that might arise from differences in inherited susceptibility. Our simple model suggests that ethnic differences in cancer occurrence can result from differences in genetic susceptibility. However, the magnitude of ethnic relative risk is likely to more strongly reflect differences in the distribution of susceptibility genotypes between groups than the magnitude of the disease risk associated with the genotypes. For many scenarios, the ethnic relative risk arising from differences in susceptibility may be bounded by the ratio of the proportion of susceptible individuals in each group.

摘要

癌症发病率在不同种族和地理位置之间存在显著差异。传统上,癌症发生的种族差异归因于社会、文化、经济和自然环境的不同。然而,鉴于新的生物学证据和致癌理论,这种对流行病学证据的解释可能需要修正。目前认为,致癌作用是一个多步骤过程,在此过程中,参与细胞生长控制和基因组稳定性的基因会发生突变或表达的可遗传变化。遗传性癌症易感性可能是癌症发病率种族差异的一个比目前所认识到的更强的决定因素。为了研究遗传性易感性的潜在作用,我们使用一个简单的概率模型来考量遗传性易感性对发病率种族差异的理论贡献。以肿瘤抑制基因BRCA1和p53的种系突变为例,来说明遗传性易感性差异可能导致的乳腺癌种族差异程度。我们的简单模型表明,癌症发生的种族差异可能源于遗传易感性的差异。然而,种族相对风险的大小可能更强烈地反映出不同群体之间易感性基因型分布的差异,而不是与这些基因型相关的疾病风险大小。在许多情况下,由易感性差异引起的种族相对风险可能受每组易感个体比例之比的限制。

相似文献

1
Ethnic differences in cancer incidence: a marker for inherited susceptibility?癌症发病率的种族差异:遗传性易感性的一个指标?
Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):897-900. doi: 10.1289/ehp.97105s4897.
2
Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.亚洲的遗传性乳腺癌和卵巢癌:BRCA1和BRCA2的遗传流行病学
Hum Mutat. 2002 Dec;20(6):413-24. doi: 10.1002/humu.10154.
3
BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.克什米尔一个新兴高风险地区特定种族人群乳腺癌的BRCA1和TP53基因突变谱。
Cancer Lett. 2007 Apr 18;248(2):308-20. doi: 10.1016/j.canlet.2006.08.012. Epub 2006 Sep 22.
4
5
The contribution of inherited predisposition to cancer incidence.遗传易感性对癌症发病率的影响。
Cancer Surv. 1990;9(3):395-416.
6
Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.具有遗传易感性的女性腹膜癌:对犹太人群的影响。
Fam Cancer. 2004;3(3-4):265-81. doi: 10.1007/s10689-004-9554-y.
7
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.印度乳腺癌患者中乳腺癌易感基因BRCA1、BRCA2和p53基因的新型种系突变。
Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8.
8
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.治疗相关髓系肿瘤患者中 DNA 损伤反应基因 BRCA1、BRCA2、BARD1 和 TP53 的种系突变。
J Med Genet. 2012 Jul;49(7):422-8. doi: 10.1136/jmedgenet-2011-100674. Epub 2012 May 31.
9
Epidemiology of susceptibility to breast cancer.乳腺癌易感性的流行病学
Prog Clin Biol Res. 1996;395:159-74.
10
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.BRCA1和BRCA2突变携带者中早发性乳腺癌的不同分子发病机制:一项基于人群的研究。
Cancer Res. 1999 Apr 15;59(8):2011-7.

引用本文的文献

1
Long-term outcomes of primary cardiac malignant tumors: Difference between African American and Caucasian population.原发性心脏恶性肿瘤的长期预后:非裔美国人和白种人群体之间的差异。
Cancer Med. 2021 Dec;10(24):8838-8845. doi: 10.1002/cam4.4385. Epub 2021 Nov 11.
2
DNMT3B -579 G>T Promoter Polymorphism and the Risk of Gastric Cancer in the West of Iran.DNMT3B基因 -579位点G>T启动子多态性与伊朗西部胃癌风险
J Gastrointest Cancer. 2018 Jun;49(2):167-171. doi: 10.1007/s12029-017-9928-7.
3
Minority ethnicity patient satisfaction and experience: results of the National Cancer Patient Experience Survey in England.少数民族患者的满意度和体验:英格兰国家癌症患者体验调查结果。
BMJ Open. 2016 Jun 28;6(6):e011938. doi: 10.1136/bmjopen-2016-011938.
4
Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.HBOC高危患者中BRCA1、BRCA2、CHEK2和TP53的生殖系突变:对巴西东北部人群的特征分析
Hum Genome Var. 2014 Oct 16;1:14012. doi: 10.1038/hgv.2014.12. eCollection 2014.
5
Endothelin-1 but not Endothelial Nitric Oxide Synthase Gene Polymorphism is Associated with Sickle Cell Disease in Africa.内皮素-1而非内皮型一氧化氮合酶基因多态性与非洲镰状细胞病相关。
Gene Regul Syst Bio. 2014 May 25;8:119-26. doi: 10.4137/GRSB.S14836. eCollection 2014.
6
Quantitative assessment of the association between MHTFR C677T (rs1801133, Ala222Val) polymorphism and susceptibility to bladder cancer.MHTFR C677T(rs1801133,Ala222Val)多态性与膀胱癌易感性的关联的定量评估。
Diagn Pathol. 2013 Jun 17;8:95. doi: 10.1186/1746-1596-8-95.
7
Allele Frequencies of the Epidermal Growth Factor Receptors Polymorphism R521K in Colorectal Cancer Patients and Healthy Subjects Indicate a Risk-Reducing Effect of K521 in Syrian Population.表皮生长因子受体多态性R521K在结直肠癌患者和健康受试者中的等位基因频率表明K521在叙利亚人群中有降低风险的作用。
N Am J Med Sci. 2013 Mar;5(3):202-6. doi: 10.4103/1947-2714.109189.
8
Extensive ethnogenomic diversity of endothelial nitric oxide synthase (eNOS) polymorphisms.内皮型一氧化氮合酶(eNOS)多态性的广泛种族基因组多样性。
Gene Regul Syst Bio. 2013;7:1-10. doi: 10.4137/GRSB.S10857. Epub 2013 Jan 15.
9
CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies.CYP1A2 rs762551 多态性与癌症易感性有关:来自 19 项病例对照研究的荟萃分析。
BMC Cancer. 2012 Nov 19;12:528. doi: 10.1186/1471-2407-12-528.
10
Expression of CA125 and cisplatin susceptibility of pleural effusion-derived human lung cancer cells from a Thai patient.一名泰国患者胸腔积液来源的人肺癌细胞中CA125的表达及顺铂敏感性
Oncol Lett. 2012 Aug;4(2):252-256. doi: 10.3892/ol.2012.711. Epub 2012 May 10.

本文引用的文献

1
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.瑞典南部遗传性乳腺癌和卵巢癌中BRCA1基因的奠基性突变
Am J Hum Genet. 1996 Mar;58(3):441-50.
2
Inherited breast and ovarian cancer.遗传性乳腺癌和卵巢癌。
Hum Mol Genet. 1995;4 Spec No:1811-7. doi: 10.1093/hmg/4.suppl_1.1811.
3
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.家族性乳腺癌和卵巢癌的基因连锁分析:来自214个家庭的结果。乳腺癌连锁协会。
Am J Hum Genet. 1993 Apr;52(4):678-701.
4
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.携带BRCA1基因突变者患癌风险。乳腺癌连锁协会。
Lancet. 1994 Mar 19;343(8899):692-5. doi: 10.1016/s0140-6736(94)91578-4.
5
Antioncogenes and human cancer.抗癌基因与人类癌症。
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10914-21. doi: 10.1073/pnas.90.23.10914.
6
Pharmacogenetics: detecting sensitive populations.药物遗传学:检测敏感人群。
Environ Health Perspect. 1994 Dec;102 Suppl 11(Suppl 11):81-7. doi: 10.1289/ehp.94102s1181.
7
Germline mutation of BRCA1 in Japanese breast cancer families.日本乳腺癌家族中BRCA1的种系突变
Cancer Res. 1995 Aug 15;55(16):3521-4.
8
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.在阿什肯纳兹犹太人群体中,BRCA1基因185delAG突变的携带频率约为1%。
Nat Genet. 1995 Oct;11(2):198-200. doi: 10.1038/ng1095-198.
9
A common BRCA1 mutation in the Ashkenazim.阿什肯纳兹人群中常见的一种BRCA1基因突变。
Nat Genet. 1995 Oct;11(2):113-4. doi: 10.1038/ng1095-113.
10
The genetics of breast and ovarian cancer.乳腺癌和卵巢癌的遗传学
Br J Cancer. 1995 Oct;72(4):805-12. doi: 10.1038/bjc.1995.417.